Yoga and Physiotherapy for Sarcoidosis Fatigue and Pulmonary Function
traditional physiotherapy group
+ yoga program
Hemic and Lymphatic Diseases+4
+ Hypersensitivity
+ Hypersensitivity, Delayed
Treatment Study
Summary
Study start date: November 30, 2023
Actual date on which the first participant was enrolled.This clinical trial focuses on exploring the benefits of yoga compared to traditional physiotherapy for patients with sarcoidosis, a disease that primarily affects the lungs and is characterized by symptoms like fatigue and difficulty breathing. Sarcoidosis often leads to reduced lung function and muscle weakness, significantly impacting the quality of life. The study aims to determine how yoga, which includes breathing techniques and physical postures, might improve lung function, reduce symptoms like anxiety and depression, and enhance overall well-being alongside conventional physiotherapy. Given the limited non-drug treatment options for sarcoidosis, this research could offer valuable insights for better management of the condition. Participants in this study will engage in either yoga sessions or conventional physiotherapy programs. The treatments aim to improve lung function, exercise capacity, and mental health. Progress will be monitored through various assessments, including a six-minute walking test to gauge exercise capacity, and evaluations of anxiety, depression, fatigue levels, and sleep quality. Yoga's unique approach, which emphasizes slow and deep breathing, may help modulate body functions and alleviate symptoms associated with sarcoidosis. This study seeks to provide a comprehensive understanding of how these non-drug interventions can benefit sarcoidosis patients, potentially guiding future rehabilitation strategies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital
Istanbul, Turkey (Türkiye)Open Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital in Google Maps